3-Hydroxy-4-methoxyphenethylamine: the endogenous toxin of parkinsonism?
D065098:Catechol O-Methyltransferase Inhibitors; D002570:Ceruloplasmin; D004295:Dihydroxyphenylalanine / Q000627:therapeutic use; D004298:Dopamine / Q000378:metabolism; D004357:Drug Synergism; D006801:Humans; D008745:Methylation; D010300:Parkinson Disease / Q000209:etiology / Q000378:metabolism*; D010627:Phenethylamines / Q000378:metabolism*; D011485:Protein Binding
D065098:Catechol O-Methyltransferase Inhibitors; D010627:Phenethylamines; D004295:Dihydroxyphenylalanine; D002570:Ceruloplasmin; D004298:Dopamine